Fundraising Fox
MBX Biosciences
Carmel, US · Founded 2019 · 93 employees on LinkedIn · 7 known investors
Find your way into MBX Biosciences
Sign up to see every warm intro you have to MBX Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MBX Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MBX Biosciences is a clinical-stage biopharmaceutical company developing peptide therapeutics for endocrine and metabolic diseases. It applies expertise in peptide discovery and development to create precision peptide medicines aimed at improving treatment standards for these conditions.
Founders & leadership
MBX Biosciences was founded in 2019 by Richard DiMarchi and Peter Kent Hawryluk.
Investors · 7
How we know: the company's own site · Frazier Life Sciences's portfolio page · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: IU Ventures's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$74.8M disclosed across 3 rounds · 2019–2022
▶$46.7MraisedNov 2022 · 20 investors · PharmaceuticalsRule 506(b)
- James M. CorneliusDirector
- Patrick HeronDirector
- Edward MathersDirector
- Richard DiMarchiExecutive Officer, Director
- Tiba AynechiDirector
- Peter Kent HawrylukExecutive Officer, Director
- Ora PescovitzDirector
- Carl GordonDirector
- Richard BartramExecutive Officer
- Offering amount
- $115.2M
- Amount sold
- $46.7M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$25.8MraisedJul 2020 · 16 investors · PharmaceuticalsRule 506(b)
- Timothy KnickerbockerExecutive Officer, Director
- Richard DiMarchiExecutive Officer, Director
- Peter Kent HawrylukExecutive Officer, Director
- Offering amount
- $35.8M
- Amount sold
- $25.8M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2.3MraisedMay 2019 · 9 investors · PharmaceuticalsRule 506(b)
- Richard DiMarchiExecutive Officer, Director
- Timothy KnickerbockerExecutive Officer, Director
- Peter Kent HawrylukExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $2.3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does MBX Biosciences do?
- MBX Biosciences is a clinical-stage biopharmaceutical company developing peptide therapeutics for endocrine and metabolic diseases. It applies expertise in peptide discovery and development to create precision peptide medicines aimed at improving treatment standards for these conditions.
- Who founded MBX Biosciences?
- MBX Biosciences was founded by Richard DiMarchi, Peter Kent Hawryluk in 2019.
- Who are MBX Biosciences's investors?
- MBX Biosciences's investors include Frazier Life Sciences, Norwest Venture Partners, IU Ventures, New Enterprise Associates (NEA), OrbiMed, Wellington Management, Frazier Healthcare Partners.
- How much funding has MBX Biosciences raised?
- MBX Biosciences has disclosed $74.8M raised across 3 rounds.
- Where is MBX Biosciences headquartered?
- MBX Biosciences is headquartered in Carmel, US.